V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20159849 | 20061479 | 1.6 | 71.6 | null | 2016-02-06 | 2016-02-24 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100521222 |
| 20159851 | 20061480 | 1.7 | 82.2 | Adjuvant (A) | 2018-04-03 | 2018-04-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100910298 |
| 20159852 | 20061481 | 1.58 | 77 | Curative (C) | 2017-07-06 | 2017-07-06 | ECX | 02 | N | ECX | 101569012 |
| 20159853 | 20061482 | 1.55 | 81 | Adjuvant (A) | 2017-12-08 | 2017-12-19 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101347271 |
| 20159854 | 20061483 | 1.58 | 77 | Palliative (P) | 2017-11-14 | 2017-12-09 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101205741 |
| 20159856 | 20061484 | 1.7 | 99 | Curative (C) | 2016-05-24 | 2016-06-10 | ECX | 02 | N | ECX | 100568310 |
| 20159857 | 20061485 | 1.78 | 94 | Palliative (P) | 2018-09-09 | 2018-09-16 | ECX | 02 | N | ECX | 101870111 |
| 20159858 | 20061486 | 1.69 | 53 | Adjuvant (A) | 2016-08-18 | 2016-08-24 | ECX | 02 | N | ECX | 100471302 |
| 20159859 | 20061487 | 1.68 | 63.1 | null | 2017-08-25 | 2017-09-10 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101768091 |
| 20159862 | 20061488 | 1.79 | 93 | Palliative (P) | 2018-12-30 | 2019-01-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101852770 |
| 20159865 | 20061489 | 1.74 | 84.9 | Palliative (P) | 2017-10-18 | 2017-11-02 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100769144 |
| 20159866 | 20061490 | 1.69 | 58 | Adjuvant (A) | 2018-04-07 | 2018-04-13 | CAPECITABINE + GEMCITABINE | 99 | null | CAPECITABINE + GEMCITABINE | 100067087 |
| 20159868 | 20061491 | 1.6 | 52.3 | Neo-adjuvant (N) | 2016-03-23 | 2016-03-30 | ECX | 02 | N | ECX | 100548129 |
| 20159871 | 20061492 | 1.57 | 65.3 | Neo-adjuvant (N) | 2019-05-04 | 2019-05-18 | ECX | 02 | Y | ECX | 100322734 |
| 20159872 | 20061493 | 1.79 | 57.7 | Adjuvant (A) | 2016-06-29 | 2016-07-13 | ECX | N | N | ECX | 101468604 |
| 20159874 | 20061494 | 1.7 | 119 | Neo-adjuvant (N) | 2018-01-20 | 2018-02-08 | ECX | N | N | ECX | 101126276 |
| 20159875 | 20061495 | 1.6 | 51.4 | Adjuvant (A) | 2017-03-15 | 2017-04-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101767389 |
| 20159876 | 20061496 | 1.74 | 67 | Neo-adjuvant (N) | 2017-05-03 | 2017-05-03 | ECX | N | N | ECX | 100902066 |
| 20159878 | 20061497 | null | null | 02 | 2018-10-06 | 2018-10-13 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100441499 |
| 20159879 | 20061498 | 1.73 | 72.8 | Neo-adjuvant (N) | 2018-11-05 | 2018-11-12 | ECX | N | N | ECX | 101401662 |
| 20159880 | 20061499 | 1.71 | 64.4 | Neo-adjuvant (N) | 2017-02-06 | 2017-02-12 | ECX | N | N | ECX | 100046104 |
| 20159881 | 20061500 | 1.81 | 73.9 | Neo-adjuvant (N) | 2019-12-27 | 2020-02-01 | ECX | N | N | ECX | 101484030 |
| 20159884 | 20061501 | 1.8 | 95.5 | Neo-adjuvant (N) | 2016-11-10 | 2016-11-13 | ECX | 02 | N | ECX | 100521666 |
| 20159886 | 20061502 | 1.75 | 88.8 | Neo-adjuvant (N) | 2017-08-13 | 2017-08-26 | ECX | 02 | N | ECX | 101202231 |
| 20159888 | 20061503 | 1.67 | 81 | Adjuvant (A) | 2016-04-14 | 2016-04-14 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100123126 |
| 20159889 | 20061504 | 1.66 | 89.4 | null | 2016-10-16 | 2016-10-16 | ECX | null | N | CAPECITABINE + GEMCITABINE | 101397663 |
| 20159890 | 20061505 | 1.69 | 61 | Neo-adjuvant (N) | 2018-05-21 | 2018-06-04 | ECX | N | N | ECX | 101044307 |
| 20159891 | 20061506 | 1.78 | 55.8 | Curative (C) | 2016-09-29 | 2016-10-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101228514 |
| 20159892 | 20061507 | 1.54 | 78.8 | Adjuvant (A) | 2019-05-16 | 2019-06-11 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100755286 |
| 20159893 | 20061508 | 1.59 | 76.2 | Neo-adjuvant (N) | 2019-01-31 | 2019-02-23 | ECX | N | N | ECX | 101033968 |
| 20159896 | 20061509 | 1.8 | 70 | Adjuvant (A) | 2017-02-28 | 2017-03-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100591311 |
| 20159897 | 20061510 | 1.73 | 92 | Neo-adjuvant (N) | 2018-01-23 | 2018-01-24 | ECX | N | null | ECX | 101376799 |
| 20159899 | 20061511 | 1.7 | 108.1 | Palliative (P) | 2019-02-12 | 2019-02-18 | ECX | null | N | ECX | 100937021 |
| 20159900 | 20061512 | 1.71 | 52.4 | Adjuvant (A) | 2019-02-13 | 2019-02-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101254909 |
| 20159904 | 20061513 | 1.75 | 76.2 | Palliative (P) | 2016-04-16 | 2016-04-22 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100702385 |
| 20159906 | 20061514 | 1.61 | 73.3 | Neo-adjuvant (N) | 2018-09-12 | 2018-09-12 | ECX | N | N | ECX | 101579678 |
| 20159909 | 20061515 | 1.54 | null | Adjuvant (A) | 2019-01-02 | 2019-01-11 | ECX | 02 | N | ECX | 100103146 |
| 20159912 | 20061516 | 1.7 | 78 | Neo-adjuvant (N) | 2018-09-01 | 2018-09-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101455451 |
| 20159913 | 20061517 | 1.81 | 64.6 | Palliative (P) | 2016-09-23 | 2016-09-23 | ECX | 02 | N | ECX | 100536389 |
| 20159915 | 20061518 | 1.65 | 58.7 | Palliative (P) | 2018-02-14 | 2018-03-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100622260 |
| 20159919 | 20061519 | 1.63 | 51.2 | Palliative (P) | 2018-11-18 | 2018-12-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100954173 |
| 20159920 | 20061520 | 1.75 | 89 | Palliative (P) | 2016-12-28 | 2017-01-26 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100588474 |
| 20159923 | 20061521 | 1.7 | 62.2 | Neo-adjuvant (N) | 2016-06-28 | 2016-06-28 | ECX | 02 | N | ECX | 100668183 |
| 20159924 | 20061522 | 1.98 | 103.3 | Palliative (P) | 2016-08-14 | 2016-09-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100090939 |
| 20159925 | 20061523 | 1.56 | 127 | null | 2019-10-18 | 2019-11-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101635906 |
| 20159926 | 20061524 | 1.75 | 74 | Neo-adjuvant (N) | 2019-01-23 | 2019-02-05 | ECX | 2 | Y | ECX | 101613665 |
| 20159927 | 20061525 | 1.68 | 56.5 | Neo-adjuvant (N) | 2021-03-24 | 2021-03-28 | ECX | N | N | ECX | 100919322 |
| 20159928 | 20061526 | 1.64 | 66.7 | null | 2017-11-30 | 2017-11-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100487423 |
| 20159929 | 20061527 | 1.69 | 104 | Palliative (P) | 2018-12-31 | 2018-12-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101370461 |
| 20159930 | 20061528 | 1.67 | 61 | Adjuvant (A) | 2016-10-29 | 2016-11-05 | ECX | N | N | ECX | 100392261 |